PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ACRV vs. VTGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ACRV and VTGN is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ACRV vs. VTGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Acrivon Therapeutics Inc. Common Stock (ACRV) and VistaGen Therapeutics, Inc. (VTGN). The values are adjusted to include any dividend payments, if applicable.

-40.00%-20.00%0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
1.51%
-31.50%
ACRV
VTGN

Key characteristics

Sharpe Ratio

ACRV:

0.38

VTGN:

-1.02

Sortino Ratio

ACRV:

1.57

VTGN:

-1.77

Omega Ratio

ACRV:

1.18

VTGN:

0.81

Calmar Ratio

ACRV:

0.48

VTGN:

-0.55

Martin Ratio

ACRV:

1.67

VTGN:

-1.51

Ulcer Index

ACRV:

24.58%

VTGN:

35.97%

Daily Std Dev

ACRV:

107.87%

VTGN:

53.10%

Max Drawdown

ACRV:

-85.34%

VTGN:

-99.20%

Current Drawdown

ACRV:

-71.08%

VTGN:

-98.91%

Fundamentals

Market Cap

ACRV:

$217.95M

VTGN:

$67.66M

EPS

ACRV:

-$2.66

VTGN:

-$0.74

Total Revenue (TTM)

ACRV:

$1.88M

VTGN:

$875.70K

Gross Profit (TTM)

ACRV:

$1.31M

VTGN:

$435.00K

EBITDA (TTM)

ACRV:

-$84.67M

VTGN:

-$45.23M

Returns By Period

In the year-to-date period, ACRV achieves a 36.38% return, which is significantly higher than VTGN's -55.35% return.


ACRV

YTD

36.38%

1M

3.23%

6M

1.51%

1Y

37.78%

5Y*

N/A

10Y*

N/A

VTGN

YTD

-55.35%

1M

-14.04%

6M

-28.73%

1Y

-54.37%

5Y*

-37.76%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ACRV vs. VTGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Acrivon Therapeutics Inc. Common Stock (ACRV) and VistaGen Therapeutics, Inc. (VTGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ACRV, currently valued at 0.38, compared to the broader market-4.00-2.000.002.000.38-1.02
The chart of Sortino ratio for ACRV, currently valued at 1.57, compared to the broader market-4.00-2.000.002.004.001.57-1.77
The chart of Omega ratio for ACRV, currently valued at 1.18, compared to the broader market0.501.001.502.001.180.81
The chart of Calmar ratio for ACRV, currently valued at 0.48, compared to the broader market0.002.004.006.000.48-0.66
The chart of Martin ratio for ACRV, currently valued at 1.67, compared to the broader market-5.000.005.0010.0015.0020.0025.001.67-1.51
ACRV
VTGN

The current ACRV Sharpe Ratio is 0.38, which is higher than the VTGN Sharpe Ratio of -1.02. The chart below compares the historical Sharpe Ratios of ACRV and VTGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
0.38
-1.02
ACRV
VTGN

Dividends

ACRV vs. VTGN - Dividend Comparison

Neither ACRV nor VTGN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ACRV vs. VTGN - Drawdown Comparison

The maximum ACRV drawdown since its inception was -85.34%, smaller than the maximum VTGN drawdown of -99.20%. Use the drawdown chart below to compare losses from any high point for ACRV and VTGN. For additional features, visit the drawdowns tool.


-80.00%-75.00%-70.00%-65.00%-60.00%JulyAugustSeptemberOctoberNovemberDecember
-71.08%
-82.41%
ACRV
VTGN

Volatility

ACRV vs. VTGN - Volatility Comparison

Acrivon Therapeutics Inc. Common Stock (ACRV) has a higher volatility of 20.73% compared to VistaGen Therapeutics, Inc. (VTGN) at 14.23%. This indicates that ACRV's price experiences larger fluctuations and is considered to be riskier than VTGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%JulyAugustSeptemberOctoberNovemberDecember
20.73%
14.23%
ACRV
VTGN

Financials

ACRV vs. VTGN - Financials Comparison

This section allows you to compare key financial metrics between Acrivon Therapeutics Inc. Common Stock and VistaGen Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab